Max Healthcare Institute Limited

NSEI:MAXHEALTH Stok Raporu

Piyasa değeri: ₹958.7b

Max Healthcare Institute Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Max Healthcare Institute yıllık ortalama 49.2% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 23.2% annual. Gelirler growing yılda ortalama 26.1% oranında artmaktadır. Max Healthcare Institute'in özkaynak karlılığı 12% ve net marjı 17.6%'dir.

Anahtar bilgiler

49.2%

Kazanç büyüme oranı

46.0%

EPS büyüme oranı

Healthcare Sektör Büyümesi29.4%
Gelir büyüme oranı26.1%
Özkaynak getirisi12.0%
Net Marj17.6%
Sonraki Kazanç Güncellemesi30 Jan 2025

Yakın geçmiş performans güncellemeleri

Recent updates

Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Nov 09
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Jul 18
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Jun 21
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Apr 14
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Mar 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 03
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Jan 08
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

Dec 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Oct 26
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Sep 20
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Jul 07
Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Jun 19
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

Apr 11
Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Mar 15
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Feb 22
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Nov 22
Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Oct 26
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Jul 15
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Mar 09
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Nov 24
Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Gelir ve Gider Dağılımı

Max Healthcare Institute nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NSEI:MAXHEALTH Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2460,08310,59012,5080
30 Jun 2456,64010,53811,7340
31 Mar 2454,06010,57611,1690
31 Dec 2351,97610,57011,6890
30 Sep 2350,0449,90111,3540
30 Jun 2347,80711,70810,2010
31 Mar 2345,62611,0359,8630
31 Dec 2242,7999,76310,0660
30 Sep 2241,1439,4379,7530
30 Jun 2239,9766,3108,6990
31 Mar 2239,3666,0518,7290
31 Dec 2137,9785,5108,2300
30 Sep 2136,1934,5167,7970
30 Jun 2132,4863,2366,5140
31 Mar 2125,080-1,3755,6570
31 Dec 2027,772-1,1772,1990
30 Sep 2022,487-2,1341,1210
30 Jun 2014,849-2,681-6130
31 Mar 2010,5905903,0490
31 Dec 1910,0812687610
30 Sep 1918,6097205490
30 Jun 1917,7193607090
31 Mar 1916,939-307590
30 Jun 1817,053-7047650
31 Mar 1817,303-3028380
31 Mar 1716,085-147210
31 Mar 1614,343-1806980
31 Mar 157,896-3814090
31 Mar 149,445-6461320

Kaliteli Kazançlar: MAXHEALTH yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: MAXHEALTH 'nin mevcut net kar marjları (17.6%) geçen yılın (19.8%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MAXHEALTH şirketinin kazançları son 5 yılda yılda 49.2% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: MAXHEALTH 'un son bir yıldaki kazanç büyümesi ( 7% ) 5 yıllık ortalamasının ( 49.2% /yıl) altındadır.

Kazançlar vs. Sektör: MAXHEALTH geçen yılki kazanç büyümesi ( 7% ) Healthcare sektörünün 29.6% performansını geride bırakmadı.


Özkaynak Getirisi

Yüksek ROE: MAXHEALTH 'nin Özsermaye Getirisi ( 12% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin